Monday, January 11, 2010

FDA approves Actemra (tocilizumab) for rheumatoid arthritis

The FDA has approved Actemra (tocilizumab) for rheumatoid arthritis.

The U.S. Food and Drug Administration approved Actemra (tocilizumab) on Friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis.

Read the full FDA Press Release here.

Actemra is marketed by San Francisco-based Genentech Inc., a subsidiary of the Roche Group.


  1. I need Actemra to try for my severe RA, but I have been told no one knows the FDA code for the insurance billing! I have medicare and this is the only thing that is holding things up for me!

  2. Go to for information.